Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-08-01
1999-10-19
Wax, Robert A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
424 851, A61K 3818
Patent
active
059689056
ABSTRACT:
The protein, cholinergic neuronal differentiation factor (CDF), also known as leukemia inhibitory factor (LIF), is described, together with the use of the polypeptide to stimulate neuron growth and survival in animals either by direct administration or by autotransplantation of adrenal medullary cells converted to the cholinergic phenotype.
REFERENCES:
patent: 4892538 (1990-01-01), Aebischer et al.
patent: 4997929 (1991-03-01), Collins et al.
patent: 5370870 (1994-12-01), Wong et al.
Metcalf et al., "Fatal Syndrome in Mice Engrafted with Cells Producing High Levels of the Leukemia Inhibitory Factor," Proc. Natl. Acad. Sci. USA, 86(15):5948-5952 (1989).
Dunnett et al., "Acetylcholine-Rich Neuronal Grafts in the Forebrain of Rats: Effects of Environmental Enrichment, Neonatal Noradrenaline Depletion, Host Transplantation Site and Regional Source of Embryonic Donor Cells on Graft Size and Acetylcholinesterase-Positive Fibre Outgrowth," Brain Research, 378:357-373 (1986).
Norris, D.O., "Vertebrate Endocrinology" 2nd ed, Lea & Febiger:Philadelphia, pp. 238-249 (1985).
Estrov et al., "The Modulatory Hematopoietic Activities of Leukemia Inhibitory Factor," Leukemia and Lymphoma, 8:1-7 (1992).
Schehr, R.S., "Therapeutic Approaches to Alzheimer's Disease: An Informal Survey of Promising Drug Discovery Strategies," Bio/Technology, 12:140-144 (1994).
U.S. Congress, Office of Technology Assessment, "Neural Grafting: Repairing the Brain and Spinal Cord," OTA-BA-462, U.S. Government Printing Office:Washington, D.C., pp. 37-57 (1990).
Barres et al., "Multiple Extracellular Signals are Required for Long-Term Oligodendrocyte Survival," Development, 118:283-295 (1993).
Hilton et al., "Leukemia Inhibitory Factor: A Biological Perspective," Journal of Cellular Biochemistry, 46:21-26 (1991).
Yamamori et al., "The Cholinergic Neuronal Differentiation Factor from Heart Cells is Indentical to Leukemia Inhibitory Factor," Science, 246:1412-1416 (1989).
Cheema et al., "Leukemia Inhibitory Factor (LIF) Prevents the Death of Axotomized Sensory Neurons in Newborn Rat Dorsal Root Ganglion (DRG) In Vivo," So. Neurosci. Abstract, Abstract 27.2 18(1):47 (1992).
Richards et al., "Leukemia Inhibitory Factor Promotes the Neuronal Developmental of Spinal Cord Precursors From the Neural Tube," Journal of Neuroscience Research, 33:476-484 (1992).
Fukada, K., "Purification and Partial Characterization of a Cholinergic Neuronal Differentiation Factor," Proc. Natl. Acad. Sci. USA, 82:8795-8799 (1985).
Metcalf et al., Blood 76:50-56, Jul. 1990.
Bugaisky Gabriel E.
California Institute of Technology
Wax Robert A.
LandOfFree
Stimulation of nerve growth and/or vitality does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stimulation of nerve growth and/or vitality, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stimulation of nerve growth and/or vitality will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2055433